Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients

HIV Medicine

Volumn 7, Issue 8, 2006, Pages 549-557

  Orlando, Giovanna ^a   Meraviglia, P ^a   Cordier, L ^a   Meroni, L ^a   Landonio, S ^a   Giorgi, R ^a   Fasolo, M ^a   Faggion, I ^a   Riva, A ^a   Zambelli, A ^a   Beretta, R ^a   Gubertini, G ^a   Dedivitiis, G ^a   Jacchetti, G ^a   Cargnel, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Antiretrovirals; Comorbidities; Older HIV infected patients; Toxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CHOLESTEROL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; PROTEINASE INHIBITOR; TRIACYLGLYCEROL; VIRUS RNA;

ADULT; AGE; ARTICLE; BLOOD TRANSFUSION; BONE MARROW DISEASE; CARDIOVASCULAR DISEASE; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; DYSLIPIDEMIA; ENDOCRINE DISEASE; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEALTH CARE FACILITY; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INTRAVENOUS DRUG ABUSE; ITALY; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; METABOLIC DISORDER; NEUROLOGIC DISEASE; PATIENT COMPLIANCE; PATIENT MONITORING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; AGE FACTORS; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; COMORBIDITY; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; ITALY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 33750994354     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2006.00420.x     Document Type: Article

References (19)

1. Stoff DM, Khalsa JH, Monjan A, Portegies P. Introduction: HIV/AIDS and aging. AIDS 2004; 18 (Suppl. 1): S1-S2.
2. Suligoi B, Boros S, Camoni L, Lepore D. Aggiornamento dei casi di AIDS notificati in Italia e delle nuove diagnosi di HIV al 31 Dicembre. Not Ist Super Sanità 2005; 18 (Suppl. 1).
3. Skiest DJ, Rubinstien E, Carley N et al. The importance of comorbidity in HIV-infected patients over 55 a retrospective case-control study. Am J Med 1996; 101: 605-611.
4. Adler WH, Baskar PV, Chrest FJ et al. HIV infection and aging: mechanisms to explain the accelerated rate of progression in the older patient. Mech Ageing Dev 1997; 96: 137-155.
5. Operskalski EA, Stram DO, Lee H et al. Human immunodeficiency virus type 1 infection: Relationship of risk group and age to rate of progression to AIDS. Transfusion Safety Group. J Infect Dis 1995; 172: 648-655.
6. + T-cell counts. J Acquir Immune Defic Syndr 1991;4: 970-975.
7. Sutin DG, Rose DN, Mulvihill M et al. Survival of elderly patients with transfusion-related acquired immunodeficiency syndrome. J Am Geriatr Soc 1993; 41: 214-216.
8. Perez JL, Moore RD. Greater effect of highly active antiretroviral therapy on survival in people aged >50 years compared with younger people in an urban observational cohort. Clin Infect Dis 2003; 36: 212-218.
9. DHHS. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. http://AIDSinfo.nih.gov, DHHS, 2005.
10. Grabar S, Kousignian I, Sobel A et al. Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV. AIDS 2004; 18: 2029-2038.
11. Braithwaite RS, Justice AC, Chang CCH et al. Estimating the proportion of patients infected with HIV who will die of comorbid conditions. Am J Med 2005; 118: 890-898.
12. Barbaro G. Pathogenesis of HIV-associated heart disease. AIDS 2003; 17 (Suppl.): S12-S20.
13. Aoun S, Ramos E. Hypertension in the HIV-infected patients. Curr Hypertension Rep 2000; 2: 478-481.
14. Seabberg EC, Munoz A, Lu M et al. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 2005; 19: 953-960.
15. Kamin DS, Grinspoon SK. Cardiovascular disease in HIV-positive patients. AIDS 2005; 19: 641-652.
16. Dekker JM, Girman C, Rhodes T et al. Metabolic Syndrome and 10-year cardiovascular disease risk in the Hoorn study. Circulation 2005; 112: 666-673.
17. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean R, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med 2003; 163: 2716-2724.
18. Justice AC, McGinnis KA, Atkinson JH et al. Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans aging cohort five site study. AIDS 2004; 18 (Suppl. 1): S49-S59.
19. Chesney MA, Chambers DB, Taylor JM, Johnson LM. Social support, distress, and well-being in older men living with HIV infection. J Acquir Immune Defic Syndr 2003; 33: S185-S193.